MONTREAL — Lawyers involved in a significant class-action lawsuit regarding the medication Rexulti have announced that a settlement agreement has been reached amounting to $4.75 million. This settlement is meant to benefit patients, as well as the estates and families of those who had been prescribed the drug.
The class action encompasses individuals in Canada who were prescribed Rexulti from February 16, 2017, to the present and who subsequently experienced compulsive behaviors or impulse-control disorders. These disorders include compulsive gambling, hypersexuality, compulsive spending, shopping, or binge-eating. Rexulti is primarily an antipsychotic medication utilized in the treatment of schizophrenia and depression.
A public notice detailing the settlement was released on Saturday by the Toronto-based law firm Rochon Genova. It is important to note that the Quebec Superior Court has not made any determinations regarding the merits of the claims brought forward. The settlement represents a compromise of disputed claims, and it does not involve any admission of liability or wrongdoing from the defendants involved.
The Quebec Superior Court granted authorization for the national class action against the manufacturers of Rexulti in 2024, laying the groundwork for the legal proceedings that have unfolded since then. As the situation develops, lawyers are scheduled to appear before the Quebec Superior Court in Montreal on October 31, 2025, for a settlement approval hearing. This hearing will play a critical role in finalizing the terms of the settlement and ensuring fairness for all parties involved.
This legal development highlights ongoing concerns about the potential side effects of pharmaceutical drugs, particularly those relating to mental health treatment. The issues raised in this class action spotlight the importance of taking patient testimonies and experiences seriously, especially in cases where side effects could lead to significant lifestyle changes and challenges.
As the scheduled hearing date approaches, both the legal representatives of the plaintiffs and the defendants will prepare to address the court, aiming to ensure that the settlement upholds the interests of those affected while also navigating the complexities inherent in class-action lawsuits.
